Obesity (Silver Spring) 14:10281037 Holsen LM, Savage CR, Martin LE, Bruce AS, Lepping RJ, Ko E, Brooks WM, Butler MG, Zarcone JR, Goldstein JM (2012) Importance of reward and prefrontal circuitry in hunger and satiety: PraderWilli syndrome vs simple obesity
Brief excursions, like the few minutes it takes to draw a dose, are not a problem
Maintaining weight loss after the initial phase Weight loss on retatrutide typically follows a pattern: rapid loss during the first 24-36 weeks of dose escalation, continued but slower loss through weeks 36-68, then gradual stabilization as you approach a new set point
It has a genuine FDA-approval history rather than being a novel "research chemical," but no FDA-approved finished product remains on the market, so it is supplied only through compounding pharmacies and prescribed off-label in adults for growth-hormone-axis support, general wellness, or anti-aging purposes rather than its original pediatric indication